scispace - formally typeset
S

Shu-Yuan Liao

Researcher at University of California, Irvine

Publications -  32
Citations -  3052

Shu-Yuan Liao is an academic researcher from University of California, Irvine. The author has contributed to research in topics: Gynecologic oncology & Adenocarcinoma. The author has an hindex of 21, co-authored 32 publications receiving 2929 citations. Previous affiliations of Shu-Yuan Liao include Academy of Sciences of the Czech Republic & City of Hope National Medical Center.

Papers
More filters
Journal ArticleDOI

Expression of Hypoxia-Inducible Cell-Surface Transmembrane Carbonic Anhydrases in Human Cancer

TL;DR: The studies show an important causal link between hypoxia, extracellular acidification, and induction or enhanced expression of these enzymes in human tumors and conclude that the cell surface transmembrane carbonic anhydrases CA IX and CA XII are overexpressed in many tumors suggesting that this is a common feature of cancer cells that may be required for tumor progression.
Journal Article

Identification of the MN/CA9 Protein As a Reliable Diagnostic Biomarker of Clear Cell Carcinoma of the Kidney

TL;DR: It is concluded that MN/CA9 protein expression could serve as a valuable adjunct to the cytological and histological diagnosis of benign renal cysts versus cystic R CC, adenoma versus RCC, and oncocytoma versus granular cell RCC.
Journal ArticleDOI

Identification of the MN/CA9 Protein as a Reliable Diagnostic Biomarker of Clear Cell Carcinoma of the Kidney

TL;DR: The MN/CA9 protein is a tumorassociated antigen that has been shown to have diagnostic utility in identifying cervical dysplasia and carcinoma as mentioned in this paper, but it is limited to very few normal tissues.
Journal ArticleDOI

Transcriptional control of the tumor- and hypoxia-marker carbonic anhydrase 9: A one transcription factor (HIF-1) show?

TL;DR: The existing data support the notion that CA9, due to the unique structure of its promoter, is one of the most sensitive endogenous sensors of HIF-1 activity.
Journal ArticleDOI

Extraovarian peritoneal serous papillary carcinoma: a case-control retrospective comparison to papillary adenocarcinoma of the ovary

TL;DR: The data suggest that EPSPC is clinically similar to PSOC and support the need for a prospective clinical trial to compare these two entities further, and there were no significant differences in tumor response to therapy, disease-free interval, and actuarial survival between cases and controls.